Evidence map›Paper›PMID 32438482›Full record

ArticleBritish journal of haematology2020

Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.

Gordon Cook, A John Ashcroft, Guy Pratt, Rakesh Popat, Karthik Ramasamy, Martin Kaiser, Matthew Jenner, Sarah Henshaw, Rachel Hall, Jonathan Sive and 7 more

Abstract readLetter
In one paragraph

Article in British journal of haematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Gordon CookLeeds Institute of Clinical Trial Research & Leeds Cancer Centre, University of Leeds, Leeds, UK.ORCID 0000-0003-1717-0412
A John AshcroftDepartment of Haematology, Pinderfields Hospital, Mid Yorkshire NHS Trust, Wakefield, UK.
Guy PrattUniversity Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.ORCID 0000-0002-6937-2852
Rakesh PopatDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0001-6553-4618
Karthik RamasamyNIHR BRC Blood Theme, Oxford University Hospitals NHS FT, Oxford, UK.
Martin KaiserThe Institute of Cancer Research, London, UK.ORCID 0000-0002-3677-4804
Matthew JennerUniversity Hospital Southampton NHS Foundation Trust, Southampton, UK.
Sarah HenshawDepartment of Haematology, Nottingham City Hospital, Nottingham, UK.
Rachel HallThe Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, UK.
Jonathan SiveDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Simon SternDepartment of Haematology, Epsom & St Helier University Hospitals NHS Trust, Carshalton, UK.
Matthew StreetlyDepartment of Haematology, Guys and St Thomas's Trust, London, UK.
Ceri BygraveDepartment of Haematology, University Hospital of Wales, Cardiff, UK.ORCID 0000-0002-1571-0692
Richard SoutarThe Beatson West of Scotland Cancer Centre, Glasgow, UK.
Neil RabinDepartment of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Graham H JacksonNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
United Kingdom Myeloma Forum

Funding

Cancer Research UK 25447
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAntineoplastic AgentsBetacoronavirusClinical AuditCoronavirus InfectionsCOVID-19FemaleHumansMaleMiddle AgedMultiple MyelomaPandemicsPneumonia, ViralRecurrenceSARS-CoV-2Antineoplastic AgentsCOVID-19multiple myelomasystemic antic-cancer therapy

Identifiers

PMID32438482
PMCPMC7280609

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.